EAACI Congress 2025
BackFT02 - Anaphylaxis, new perspectives and treatments
Friday 13 Jun, 13:15 PM -
14:45 PM Glasgow, United Kingdom
Dochart 1
Flash Talks
13:15
001319
Risk of Anaphylaxis in Patients with Large Local Reactions to Hymenoptera Stings: Retrospective and Prospective study
13:22
001196
Pharmacokinetics and Pharmacodynamics following repeat dosing of ARS-1 (adrenaline nasal spray) versus intramuscular injection during induced allergic rhinitis: sub-analysis
13:29
001519
The Cross-Canada Registry for Anaphylaxis Fatalities (CRAFT ): Demographics , Triggers, Co-factors and Management
13:36
001340
Development of a Validated, Updated North American Anaphylaxis Management Plan
13:43
000922
Cold-Induced Anaphylaxis: New Perspectives on Clinical and Genetic Characteristics
13:50
001428
Prescription rates of adrenaline autoinjectors in Austria – a population-based study
13:57
001423
Pharmacokinetics by Adrenaline Products from Various Studies
14:04
001135
Adrenaline-use during the acute treatment of anaphylaxis – data from the European Anaphylaxis Registry
14:11
000953
Pollen induces pseudo-allergy via MRGPRX2/Mrgprb2 on mast cells
14:18
000513
Circulating mastocyte-derived prostaglandins in perioperative anaphylaxis
14:25
001333
Risk factors for severe food anaphylaxis; data from the Allergy-Vigilance Network
